 ROCKVILLE, Md., Sept. 02, 2021 GLOBE NEWSWIRE -- Supernus Pharmaceuticals, Inc. Nasdaq: SUPN, a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system CNS diseases, today announced that the Companys management will participate and host investor meetings in the following upcoming September 2021 virtual investor conferences. 